Proteins with anti-inflammatory and antioxidant properties, such as Fibronectin Type III Domain Containing Protein 4 (FNDC4) and glutathione peroxidase 7 (GPx7), play protective roles against MASLD progression. The gene discussed is FNDC4; the disease is metabolic dysfunction-associated steatotic liver disease.